Stock 300026 TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Tianjin Chase Sun Pharmaceutical Co.,Ltd

Equities

300026

CNE100000GF1

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-06-25 pm EDT 		5-day change 1st Jan Change
3.16 CNY +4.29% Intraday chart for Tianjin Chase Sun Pharmaceutical Co.,Ltd -1.56% -25.47%
Mar. 29 Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023 CI
Mar. 01 Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023
Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Tianjin Chase Sun Pharma’s Muscle Relaxant Passes Drug Consistency Test
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Tianjin Chase Sun Pharmaceutical Co.,Ltd. Approves Final Cash Dividend for A Shares for the Year 2022, Payable on 12 May 2023
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2022
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Profit Distribution Proposal for 2022
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2021, Payable on May 19, 2022
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2021
Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Cash Dividend for 2021
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300026 Stock
  4. News Tianjin Chase Sun Pharmaceutical Co.,Ltd
  5. Other languages